Showing results (1-10 of 348) with videos related to
Sort By:
Pageof 35
Current Topics in Medicinal Chemistry|January 29, 2008
Activity of gamma-secretase on substrates other than APPAlberto LleóCurrent Topics in Medicinal Chemistry|April 23, 2011
γ-secretase substrates and their implications for drug development in Alzheimer's diseaseAlberto Lleó, Carlos A SauraFrontiers of Neurology and Neuroscience|July 28, 2016
Cerebrospinal Fluid Biomarkers for Target Engagement and Efficacy in Clinical Trials for Alzheimer's and Parkinson's DiseasesLucilla Parnetti, Paolo Eusebi, Alberto LleóCNS & Neurological Disorders Drug Targets|October 15, 2010
Tau phosphorylation and aggregation as a therapeutic target in tauopathiesNahuai Badiola, Marc Suárez-Calvet, Alberto LleóNeuroscience Letters|January 23, 2002
Uncommon polymorphism in the presenilin genes in human familial Alzheimer's disease: not to be mistaken with a pathogenic mutationAlberto Lleó, Magda Castellví, Rafael Blesa, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|January 26, 2019
Has the time arrived for cerebrospinal fluid biomarkers in psychiatric disorders?Alberto Lleó, Lucilla Parnetti, Olivia Belbin, et al.Alzheimer'S Research & Therapy|July 2, 2024
APP dyshomeostasis in the pathogenesis of Alzheimer's disease: implications for current drug targetsSònia Sirisi, Érika Sánchez-Aced, Olivia Belbin, et al.Developmental Neurobiology|July 7, 2019
Down syndrome, Alzheimer disease, and cerebral amyloid angiopathy: The complex triangle of brain amyloidosisMaría Carmona-Iragui, Laura Videla, Alberto Lleó, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 11, 2004
Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutationsAlberto Lleó, Oksana Berezovska, John H Growdon, et al.Pageof 35